Atlas Trials

Low Dose CdA Combined With Valproic Acid (VPA) in Previously Treated B-cell Chronic Lymphocytic Leukemia(B-CLL)

Clinical trial NCT01295593 · UNKNOWN

Trial details

NCT number
NCT01295593
Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Chronic Lymphocytic Leukemia
Start date
2010-12-01
Primary completion
2013-04-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.